Vizimpro

Vizimpro ATC Classification

dacomitinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma

NEW Brand Resources

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Full Prescribing Info

ATC Classification

L01EB07 - dacomitinib ; Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.

Sign up for Free to continue reading

Continue with Google

Sign up with email

Already a member? Sign in